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Abstract
Background: Nurses’ recognition of clinical deterioration is crucial for patient survival. Evidence for the
effectiveness of modified early warning scores (MEWS) is derived from large observation studies in developed
countries.
Methods: We tested the effectiveness of the paper-based Cape Town (CT) MEWS vital signs observation chart and
situation-background-assessment-recommendation (SBAR) communication guide. Outcomes were: proportion of
appropriate responses to deterioration, differences in recording of clinical parameters and serious adverse events
(SAEs) in intervention and control trial arms. Public teaching hospitals for adult patients in Cape Town were
randomised to implementation of the CT MEWS/SBAR guide or usual care (observation chart without track-and-
trigger information) for 31 days on general medical and surgical wards. Nurses in intervention wards received
training, as they had no prior knowledge of early warning systems. Identification and reporting of patient
deterioration in intervention and control wards were compared. In the intervention arm, 24 day-shift and 23 night-
shift nurses received training. Clinical records were reviewed retrospectively at trial end. Only records of patients
who had given signed consent were reviewed.
Results: We recruited two of six CT general hospitals. We consented 363 patients and analysed 292 (80.4%) patient
records (n = 150, 51.4% intervention, n = 142, 48.6% control arm). Assistance was summoned for fewer patients with
abnormal vital signs in the intervention arm (2/45, 4.4% versus (vs) 11/81, 13.6%, OR 0.29 (0.06–1.39)), particularly
low systolic blood pressure. There was a significant difference in recording between trial arms for parameters listed
on the MEWS chart but omitted from the standard observations chart: oxygen saturation, level of consciousness,
pallor/cyanosis, pain, sweating, wound oozing, pedal pulses, glucose concentration, haemoglobin concentration,
and “looks unwell”. SBAR was used twice. There was no statistically significant difference in SAEs (5/150, 3.3% vs 3/
143, 2.1% P = 0.72, OR 1.61 (0.38–6.86)).
Conclusions: The revised CT MEWS observations chart improved recording of certain parameters, but did not
improve nurses’ ability to identify early signs of clinical deterioration and to summon assistance. Recruitment of
only two hospitals and exclusion of patients too ill to consent limits generalisation of results. Further work is
needed on educational preparation for the CT MEWS/SBAR and its impact on nurses’ reporting behaviour.
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Introduction
Nurses are responsible for monitoring patients for signs
of clinical deterioration. These might be most effectively
detected using bedside early warning scoring (EWS) sys-
tems and a standardised reporting system such as the
situation-background-assessment-recommendation
(SBAR) guide. In 2010 we conducted our first pragmatic,
cluster randomised controlled trial (RCT) of the original,
consensus-derived, Cape Town (CT) modified EWS
(MEWS) observations chart in three intervention and
three control adult surgical wards in a single research
site [1–3]. At the time, electronic track-and-trigger
MEWS and reporting systems were increasingly widely
used in healthcare settings in developed countries [4–6],
whereas pen-and-paper systems were slowly being im-
plemented in developing countries [1, 7]. As in our trial,
government sector hospital wards in low-income and
middle-income countries in Africa used pen-and-paper
graphic charts to plot temperature, blood pressure, heart
and respiratory rates, without information on normal or
expected values [1]. Paper charting of observations takes
longer than electronic systems, increasing nursing work-
load [8] and risk of human error [9], particularly in-
accuracy of calculations [10].
From our trial, we concluded that the original CT
MEWS chart and training programme enhanced record-
ing of respiratory rate and all parameters, and nurses’
knowledge, but not nurses’ responses to patients who
triggered the MEWS reporting algorithm. At the conclu-
sion of the trial we were required to withdraw the CT
MEWS because this was an independent rather than a
government-endorsed study. Nevertheless, we were in-
spired by the Royal College of Physicians’ National Early
Warning Score (NEWS) [11] to revise the CT MEWS
chart under the Creative Commons Attribution-No De-
rivatives 4.0 International Licence (Additional file 1),
and to undertake a further RCT.
Changes in clinical parameters, such as pallor and re-
duced level of consciousness, and abnormal physio-
logical vital signs herald patient deterioration, often 6–8
h before the onset of a serious adverse event (SAE) [12].
To help nurses recognise deterioration, physiological
values are recorded on MEWS charts within partitioned
coloured bands (cut points or thresholds) with corre-
sponding colour-coded weighted trigger points (scores)
(0, upper and lower 1–3) (Additional file 1). If nurses
are not adequately trained in recognition of deterior-
ation, absence of trigger points may restrict nurses’
capacity to summon clinical assistance when needed.
Educational programmes normally accompany imple-
mentation of EWS/MEWS [13]. A systematic review
reported effectiveness of educational interventions
(mainly simulation) in recognition and management of
deteriorating patients, improved patient outcomes and
organisational systems. The review identified 20 quanti-
tative studies, 2 mixed methods studies and 1 qualitative
study (total n = 23): 11 of 20 (55.0%) studies indicated a
statistically significant improvement in knowledge, clin-
ical performance, use of medical emergency teams
(METs), frequency of observations, and patient out-
comes [13]. Improvement in confidence in approaching
senior staff for advice and working as a team were also
reported [13].
A systematic review of 11 articles (10 studies) on the
effect of EWS systems training reported a statistically
significant improvement in either nurses’ knowledge or
confidence or clinical performance [14]. All studies (but
one) were conducted in countries with high human-
development indices [14].
It is not surprising, therefore, that we were unable to
locate reports of the introduction of EWS in government
sector hospitals in developing countries. At the inception
of this study, the public healthcare sector in South Africa
had commenced transitioning to a National Health In-
surance (NHI) system [15]. The outcome is a health fi-
nancing system designed to pool funds and actively
purchase services to provide access to high quality, af-
fordable personal health services for all South Africans,
irrespective of socioeconomic status. The final phase is
scheduled for 2022. A pen-and-paper recording system
will make it difficult to achieve objective evaluation of
the quality of nursing care: like all evaluations, this will
require data capture, storage and analysis to guide a
standardised approach to clinical care [16].
In the present study, we aimed to test the effectiveness
of the revised instrument (Additional file 1) and a locally
validated MEWS-linked SBAR guide (DB) (Add-
itional file 2) on hospital nurses’ performance in early
identification and paper reporting of clinical and physio-
logical deterioration in adult patients in public sector
teaching hospitals in Cape Town, South Africa. As in
our first RCT of the original CT MEWS chart, the
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second RCT of the revised MEWS was conducted de
novo without the nurses having any prior knowledge of
EWS for monitoring patients’ vital signs. To our know-
ledge this is the first multi-site RCT on the effectiveness
of a MEWS vital signs observations chart for early rec-
ognition and response to signs of deterioration [3].
Methods
Design
This was a pilot, pragmatic, parallel-group RCT with two
arms (intervention versus usual care). Pragmatic clinical
trials (PCTs) are randomised trials designed to compare
the effectiveness of interventions in real-world settings
[17] for the primary purpose of informing decision-
makers of the balance of benefits, burdens and risks [16].
Here, hospitals were the unit of randomization, that is,
random allocation of all participating general medical and
surgical wards in the hospital to the same trial arm. There
was contamination bias in our previous single-site trial
due to nurses working across wards [3].
Ethical considerations
We regarded our study as being of minimal risk, limited
to “interventions already used in routine clinical care”
([18]:486). The local University of Cate Town (UCT) Clin-
ical Research Centre (CRC) was the trial sponsor. The trial
protocol received ethical approval from the Local Human
Research Ethics Committee (HREC 337/2014), the local
Provincial Department of Health (2014RP069), and the
National Department of Health (DOH-27-0614-4779).
They determined that patients would be recruited by in-
formed, written consent for use of the revised MEWS
chart and record review (after the intervention). In the
earlier trial (HREC 192/2009) [3], individual patient con-
sent for these processes had been deemed unnecessary.
In this second RCT, recruitment by individual patient
consent soon proved impractical and hindered the deliv-
ery of the trial. We then submitted a revised protocol,
requesting a waiver of individual written consent. Subse-
quent revised HREC approval (Ref. 825/2014) required
written permission from gatekeepers for such a waiver
and hospital notices to this effect in A3 size. This was
not acceptable to some hospitals. For example, one aca-
demic tertiary hospital declined participation, stating
that the display of A3 posters in research wards, re-
placing individual patient consent, would breach their
value framework and might result in family or staff un-
happiness or public media inquiries or complaints. We
then used the earlier approval (HREC 337/2014), requir-
ing individual patient consent, without posters.
Setting
All six acute, government-sector hospitals for adult pa-
tients in the Western Cape, South Africa were matched
for level of acuity and patient numbers (three pairs)
within a predetermined distance range (124 km) from
UCT, and approached (recruitment success is described
under “Results”). Previously, in our first single-site study
[3], we observed that some staff worked across several
wards in their hospitals, often as relief or bank nurses.
Therefore, to limit contamination in this RCT, each hos-
pital was either an intervention or a control site. Before
the study we obtained, with permission, encrypted, fully
anonymised data from the Western Cape provincial De-
partment of Health database for February 2014 (admis-
sion numbers, death rate, length of stay). We compared
data to ensure that we were comparing wards and hospi-
tals with similar reporting levels for these parameters.
The trial was conducted on general medical and surgical
wards. Specialist units such as intensive care were out-
side the scope of the study. Data were obtained by retro-
spective review of patient records for both trial arms,
following the educational intervention and trial use of
the MEWS chart and SBAR guide in the intervention
arm.
Screening and randomisation
The Swansea Clinical Trials Unit randomly allocated hos-
pitals electronically to either the intervention or control
trial arm before commencement of the study. As hospitals
became available they were randomised in pairs (pre-
matched by acuity and type, as above). There were no sta-
tistically significant differences in mortality rates between
the hospitals paired for randomisation. General medical
and surgical wards were matched, resulting in the selec-
tion of two matched surgical and one medical ward in
each hospital allocated to their hospital’s trial arm. The
process of consenting nurses to training or no training in
the respective trial arms (hospitals) precluded blinding.
Outcomes
The primary outcome was nurses’ reporting behaviour,
defined as proportion of responses to early signs of clin-
ical and physiological deterioration judged as appropri-
ate, using the CT MEWS criteria for critical
deterioration labelled as “red MEWS” and scoring a 3.
Secondary outcomes were the differences between inter-
vention and control arms in (1) number of patients with
recordings in the order that these appear on the MEWS
chart (respiratory rate, oxygen saturation, temperature,
heart rate, systolic blood pressure (BP), level of con-
sciousness, urine output), (2) recordings of all seven vital
signs, (3) nurses’ responses to MEWS, and (4) the pro-
portion of patients who developed serious adverse events
(SAEs) [19]. We recorded patients’ demographic and
clinical characteristics, and prescription of opiates, seda-
tives, diuretics and anti-hypertensives received on the
day of vital sign recordings.
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Participants
Patient records for retrospective review
We aimed to evaluate effectiveness of the revised MEWS
chart by reviewing records of consented patients aged ≥
18 years, admitted in August 2014 to the study wards,
with the following exclusions: noted as “Not for Resusci-
tation”, transferred out of the ward to another depart-
ment within 12 h following admission, or pregnancy.
Clinical records of consented patients were excluded if:
1. Unavailable: in the medico-legal department (for ex-
ample after death); in the x-ray department; re-
moved for teaching purposes or transcription; in
active use in association with re-admission of the
patient; or
2. Incomplete: without a vital signs chart (in the
intervention wards, the MEWS chart) or the
nursing record/progress notes; or
3. Missing for unknown reasons.
Patients with multiple drug-resistant pulmonary tuber-
culosis were included only after data collectors were fit-
ted with the correct masks.
Sample size for record review
Our original sample size calculation was based on our pre-
vious RCT of the CT MEWS (Trial registration
PACTR201309000626545) [3], which detected a difference
of 9% between the two arms in the numbers of patients
whose abnormal vital signs triggered calls for assistance
(7/53, 13.2% vs 2/52, 3.8%). An effective sample of 300 re-
cords (150 from each arm) would have been sufficient to
detect a difference of 9% (4–13% increase) between arms
in summoning appropriate assistance with 80% power and
5% significance. This calculation took no account of clus-
tering [20, 21]. The intra-cluster correlation coefficient for
numbers of patients for whom responses were triggered
appropriately was calculated to be 0.02 (based on com-
parison of variance between and within clusters) [21].
With 12 wards potentially available and 51 patients in
each ward, the design effect is 2.0. Therefore, to give an ef-
fective sample size of 300, 612 patients had to be re-
cruited, 51 in each of 12 wards [21].
Ward nurses’ training and implementation of MEWS and
SBAR
All nurses in full-time employment in the three inter-
vention wards (31 nurses on day floor duty plus 17 on
night duty, n = 48), were eligible for participation. There
were 26 beds in each of two wards, and 30 in the third
ward (n = 82 beds). The 31 “day staff” across the three
wards comprised 9, 10 and 12 nurses, respectively, split
into two teams, working on different days of the week.
External agency nurses were hired (4 for day duty and
up to 10 for night duty depending on patient load) to
cover staffing deficits. Agency nurses on day duty did
not receive training, even though they would be using
the research instruments, because they were allocated to
different hospitals from day to day.
The eight hospital nurse managers, who did not do
floor duty, did not participate in the training sessions.
We were given a training schedule allowing 24/31
(77.4%) ward nurses on day floor duty in the three inter-
vention wards to attend on-site training; 3 clinical nurse
ward operational managers and 4 ward nurses were ex-
cluded from the training schedule. No reasons were
given for their exclusion. Six groups of 3–5 informed,
consenting nurses per session were trained (n = 24: 8
Registered Professional Nurses (RPNs), 3 RPNs on a
compulsory 2-year community service post-training
programme, 6 Enrolled (Staff) Nurses and 7 Nursing
Auxiliaries).
Informed, consented nurses on night duty (n = 23)
from the three intervention wards were trained on site
in the evenings over the same 6 days. Of these, 17 were
in full-time employment and 6 were external agency
nurses consistently stationed on night duty in the inter-
vention wards.
Intervention (1): training programme for intervention wards
An interactive 8-h classroom training programme on the
CT Mews chart and MEWS-linked SBAR communica-
tion guide was reduced by hospital managers to 2 h face-
to-face teaching. Day duty nurses were trained over 6
days in July 2014, a month before testing the instru-
ments (1–31 August 2014). The training programme (by
UK, DB) consisted of a MEWS and SBAR pocket guide,
revision of basic anatomy and physiology, followed by
recording vital signs and clinical data on blank MEWS
charts from hypothetical patient scenarios (DB). Data on
MEWS charts were then transcribed onto SBAR forms
and used for role play for calling the doctor. All nurses
were offered additional training for up to 8 h but no-one
accepted. Overall, 24/31 (77.4%) day staff and all the
night staff received training. In the control arm, nurses
were informed and consented to record review, but re-
ceived no training. Nurses in both trial arms gave writ-
ten informed consent to participate. We would have
excluded those unwilling to give signed, informed con-
sent, but this was unnecessary, as all those approached
gave written consent to participate.
Intervention (2): 31-day use of MEWS/SBAR on intervention
wards
In both trial arms, we presented the study to senior
nurses, doctors and hospital managers. Nurses in both
trial arms received a written and verbal explanation in
English, the medium of instruction in local nursing
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educational institutions. In the intervention wards,
nurses, managers and doctors agreed to use the CT
MEWS chart and SBAR guide for monitoring patients’
vital signs for 1 month. In control wards, nurses used
the usual observation chart (Additional file 3), and, if a
patient’s condition deteriorated, they followed their
usual procedure for calling for help. When patients were
discharged, researchers reviewed patients’ charts for the
quality of vital signs recordings in both trial arms.
Neither the MEWS chart nor the SBAR guide were in
use in government sector hospitals at the time of the
trial nor are they currently in use, so the concepts were
new to the nurses. The MEWS chart replaced the exist-
ing observation chart (Additional file 3) for consented
patients for the duration of the 31-day trial. A condition
of ethical approval of the study by the Western Cape
Department of Health was that hospital staff would not
be burdened with the process of obtaining consent from
patients. During the trial, two researchers (UK, DB)
interviewed patients on 11 occasions on the three inter-
vention wards.
On these occasions, written and verbal explanations of
the study were given to eligible patients in any of three
languages (English, Afrikaans and isiXhosa). For cultural
reasons, some patients requested time for discussion
with their families before giving written consent. If pa-
tients were illiterate or if they customarily deferred to
health professionals, the researchers or research assis-
tants fluent in their language read, translated and ex-
plained the consent form. In this way, we took care to
ensure that patients understood the implications of their
signed consent. Since most patients were unfamiliar with
the various forms of nursing documentation, this in-
volved explaining that researchers wanted to see the
quality of recordings of their blood pressure for example,
and nurses’ responses to any abnormal recordings.
Signed consent or a witnessed ink thumb print was
taken from every patient participating: no consent by pa-
tient consultee was authorised. No identifiable patient
data were extracted from patients’ records. The same
consenting process for record review was followed for
patients in control trial arms on 11 occasions but with
the assistance of more research assistants (SG, RR and
VvH in addition to UK) because of geographical
proximity.
Data Collection
Data collectors (RR, SG, FB, VvH) were not informed of
the study aims and objectives, to reduce observer bias
[22]. They were required to treat the data as confidential
and undertook in writing not to publish the data or any
portion thereof or any documentation relating to the
data, other than for the purpose of carrying out their
mandate.
Raw data for each patient (vital signs recordings on
the MEWS chart and data recorded on the SBAR com-
munication guide) were captured directly on IBM SPSS
datasheets (version 22 for Windows, IBM Corp 2011) on
the hard drive of a personal computer secured by
password-protected access (UK, DB). Baseline patient
clinical and demographic characteristics were located on
each patient’s personal folder and entered into the SPSS
datasheets.
Trial outcomes were assessed by criterion-based clin-
ical record review [2], for example, assistance sum-
moned: yes = 1, no = 0, and did not require subjective
interpretation. Vital signs were coded according to
MEWS criteria (lower 1, lower 2, lower 3, 0, upper 1,
upper 2, and upper 3). These criteria were used to assess
the appropriateness of responses (summoning or not
summoning assistance). Double data-entry was under-
taken by an independent investigator (SJ) on 28 (9.6%)
records randomly selected using SPSS. Following discus-
sion on interpretations, two further random samples of
7 and 34 records (total 69/292, 23.6%) were checked
[23]. Data, labelled as trial arms A and B to allow ana-
lysis to be blinded, were passed to the analyst (SJ). We
followed Consolidated standards of reporting trials
(CONSORT) guidelines extended to pragmatic RCTs
[24] (Additional file 4) and the local University of Cape
Town (UCT) (CRC) Standard Operating Procedures
(SOPs).
Data analysis
Demographic and clinical data were described for both
arms. Frequency counts and cross-tabulations were used
to compare the prevalence of documentation and re-
sponses in both arms during the study period. Where
numbers were sufficient, associations were explored in
bivariate analyses. Pearson’s chi-squared test was used to
compare proportions. Where cells contained fewer than
the minimum expected count, Fisher’s exact test was
substituted. Findings for binary outcomes were
expressed in odds ratios with 95% confidence intervals
(CIs) [25]. Small numbers of values for outcome vari-
ables precluded multivariate analyses [26].
Results
Response rate and follow up
Following provisional assurances, three of the six acute
hospitals declined to participate, leaving two matching
hospitals and a third that could not be matched. Six
wards were purposively recruited (two surgical, one
medical), respectively, in the two participating hospitals
(three wards in each hospital). The hospitals declined to
participate for various reasons (one after an 8-month
delay): recent introduction of a pilot electronic hospital
record system which included the standard vital signs
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observations chart (the MEWS was paper-based), “too
busy”, and the HREC’s approved patient consenting sys-
tem by poster was deemed unacceptable. We resorted to
individual written patient consent. This effectively ex-
cluded patients too ill to be approached and to sign fully
informed consent and those most likely to experience
SAEs, and precluded recruitment of sufficient patients to
achieve the required sample size of 612 patients, with
the expected prevalence of SAEs. We obtained written
consent from 363 patients for their records to be
reviewed: 292 (80.4%) were available for analysis, 150
(51.4%) in the intervention arm (n = 101 surgical; n = 49
medical) and 142 (48.6%) in the control arm (n = 98 sur-
gical; n = 44 medical) as shown in the CONSORT flow
diagram (Fig. 1). Three participants in the intervention
arm had no MEWS chart and were excluded, and a fur-
ther nine had no total MEWS recorded but were
retained.
Participant characteristics
Patients were not individually randomised, and we com-
pared patients in intervention and control wards. Demo-
graphic details and the prescription of opiates, sedatives,
diuretics and anti-hypertensives received on the day of
abnormal vital signs recordings are described in Table 1.
Recordings
Baseline differences in recordings of the numbers of pa-
tients with each of respiratory rate, oxygen saturation,
temperature, heart rate, systolic BP, level of consciousness,
Fig. 1 Consolidated standards of reporting trials (CONSORT) flow diagram of criterion-based record review process of the trial
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urine output and with each of the clinical signs of deteri-
oration are presented in Table 2.
There was a statistically significant difference in
recording between the trial arms for physiological
parameters listed on the MEWS observations chart
but omitted from the standard ward observations
chart: oxygen saturation (81/150, 54.0% vs 25/142,
17.6%, OR 5.49 [3.21–9.41], P < 0.001) and level of
consciousness (135/150, 90.0% vs 108/142, 76.1%,
OR 2.83 [1.47–5.47], P = 0.001). All seven vital signs
were recorded more often on the MEWS observa-
tions chart in the intervention arm than on the
standard chart in the control arm and the difference
was close to statistical significance (33/150, 22.0% vs
19/142, 13.4%, OR 1.83 [0.98–3.40]).
There was a statistically significant difference between the
trial arms for reporting clinical parameters listed on the
MEWS but not the standard chart (Table 2). Skin colour
(pallor/cyanosis), pain, sweating, wound oozing, pedal pulses
and “looks unwell” were more frequently recorded on the
MEWS. Glucose and haemoglobin levels were more fre-
quently recorded on standard charts (Table 2).
Summoning assistance
Assistance summoned for a red MEWS warning - score of 3
The primary outcome, nurses’ appropriate reporting be-
haviour, assessed from documentation in patients’ re-
cords, was disappointing in both arms. Assessment of a
patient is required immediately when a single physio-
logical parameter falls outside predetermined ranges
printed in red on the MEWS chart with a score of 3.
The number of patients with 0–4 recordings of level-3
MEWS is shown in Table 3: no patients had more than
4 such recordings. The difference between the two trial
arms in the number of patients with any vital signs re-
cordings of level-3 red MEWS was statistically signifi-
cant (45/150, 30.0% vs 81/142, 57.0%, P = < 0.001, OR
0.32 [0.20–0.52]), indicating that the control-arm partici-
pants were more likely to have disturbed physiology.
Some patients had more than one recording at red level
3. More patients in the control arm had one, two or four
such abnormal recordings. Fewer patients with abnormal
vital signs at red level 3 in the intervention arm were re-
ferred for medical attention, that is, they had assistance
summoned (2/45, 4.4% vs 11/81, 13.6%, OR 0.29 [0.06–
1.39]) (Table 3).
Physiological parameters with MEWS red (3) and yellow (2)
warning scores
While assessment of a patient is required immediately
when a single physiological parameter triggers at a score
of 3 (red) on the MEWS chart, review of a patient is re-
quired 5 min after a single physiological parameter trig-
gers at a MEWS of 2 (yellow). All abnormal recordings
of vital signs reaching the trigger thresholds of a MEWS
level 2 or 3 for respiratory rate, oxygen saturation, heart
rate, systolic BP and level of consciousness for each pa-
tient are detailed in Table 4. Some patients had more
than one recording at a MEWS level 2 or 3, but this is
not indicated in Table 4. The number of recordings of
abnormal vital signs that should have triggered at a
MEWS level 2 or 3 for these parameters reached 165 in
the intervention arm (but did not in 159/165, 96.4%)
and 178 in the control arm (but did not in 158/178,
88.8%) (Table 4).
Respiratory rate
More patients in the control arm (n = 70, 49.3%)
needed review of respiratory rate than in the inter-
vention arm (n = 43, 28.7%). The difference between
trial arms in the number of patients whose abnormal
respiratory rates triggered assistance was not statisti-
cally significant (intervention arm 1/43, 2.3% vs 1/70,
1.4% in the control arm).
There were 9 of 150 patients in the intervention arm
(6.0%) and 61 of 142 patients (42.9%) in the control arm
with a rapid respiratory rate (≥ 25 bpm) recorded,
Table 1 Baseline demographic and clinical characteristics of
patients in intervention and control arms
Characteristic Intervention arm
(n = 150)
Control arm
(n = 142)
Male, number (%) 96 (64.0) 55 (38.7)
Age in years:
Mean [SD] 53.7 [16.2] 49.9 [17.5]
Median [25th to 75th centile] 56 [40.8–65.0] 52 [34.0–62.3]
Full range 19–92 18–92
Length of stay (days):
Mean [SD] 6.0 [3.8] 8.0 [5.9]
Median [25th to 75th centile] 5.0 [3.0–7.0] 6.5 [4.0–9.3]
Full range 2–21 2–31
Pre-existing co-morbidity Number (%) Number (%)
Hypertension 71 (47.3) 48 (33.8)
Type of admission
Surgical admission 101 (67.3) 92 (64.8)
Medical admission 49 (32.7) 50 (35.2)
GA during hospitalization period 44 (29.1) 36 (25.4)
Prescription medicines and vital signs
Anti-hypertensives that daya 67 (44.4) 41 (28.9)
Diuretics that daya 53 (35.1) 30 (21.1)
Opioids that daya 104 (68.9) 32 (22.7)
Other sedatives that daya 51 (33.8) 13 (9.2)
Vital signs prescribed by doctorb 37 (24.7) 44 (31.0)
SD standard deviation, GA general anaesthetic
aThe day on which abnormal physiological result was recorded
bType and frequency of observations ordered and documented by a
medical doctor
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meeting the criterion for a single red MEWS of 3, sug-
gesting more acute illness in the control arm. None of
these triggered a response in either arm. There were no
recordings in either the intervention or control arm of a
single red MEWS for a low respiratory rate (≤ 8 bpm).
In the intervention arm, the SBAR tool was used
appropriately for one patient with a respiratory rate
of 22 breaths per minute (bpm) (MEWS of 2). In the
intervention arm most patients with abnormal respira-
tions (34/43, 22.7%) had respiratory rates between 21
and 24 bpm (MEWS of 2). In the control arm most
(61/70, 42.9%) abnormal respiratory rates were > 25
bpm. Assistance was summoned for two patients (one
in each arm) with rates of 21–24 per minute (yellow
MEWS of 2) (Table 4).
Oxygen saturation
There was a statistically significant difference between
trial arms in the number of patients whose abnormal
oxygen saturations triggered assistance (intervention
arm 0/19 vs 5/9, 55.6% in the control arm; P = 0.003,
Fisher’s exact test, Table 4). Patients in the intervention
arm were less likely to have assistance summoned. There
were 12 of 150 patients (8.0%) in the intervention arm
and 6 of 142 patients (4.2%) in the control arm with oxy-
gen saturation levels < 92%, indicating acute illness. Of
the five responses in the control arm, three (60.0%) were
for a MEWS level 3 and two (40.0%) for a MEWS level
2. The SBAR tool was not used to communicate low sat-
uration levels for 19 patients in the intervention arm: 12
were patients with saturations < 92% (MEWS of 3) and 7
were patients with 92–93% saturations (MEWS of 2)
(Table 4).
Heart rate
More patients in the intervention arm (n = 44, 29.3%)
than in the control arm (n = 37, 26.1%) required review
for an abnormal heart rate (Table 4). In the intervention
arm none of the eight recordings in the red MEWS
range of 3 for tachycardia at ≥ 131 beats per minute trig-
gered a response but there was one response for MEWS
level 2. The single recording of bradycardia at a MEWS
level 3 triggered a response. In the control arm only one
Table 2 Number of patients with physiological and clinical parameters recorded in the two trial arms
Parameter Intervention arm
n = 150
Number (%)
Control
arm
n = 142
Number (%)
OR (95% CI) Chi-square
df = 1
P value
Vital signs
RR recorded 150 (100.0) 141 (99.3)
Oxygen sats recorded 81 (54.0) 25 (17.6) 5.49 (3.21–9.41) 41.78 < 0.001
HR recorded 150 (100.0) 142 (100.0)
SBP recorded 150 (100.0) 142 (100.0)
Temperature recorded 150 (100.0) 142 (100.0)
Level of consciousness recorded 135 (90.0) 108 (76.1) 2.83 (1.47–5.47) 10.16 0.001
Urine output recordeda 41 (27.3) 66 (46.5) 0.43 (0.27–0.71) 11.51 < 0.001
Clinical parametersb
Perfusion recorded 48 (32.0) 42 (29.6) 1.12 (0.68–1.84) 0.20 0.65
Skin colour recorded 58 (38.7) 9 (6.3) 9.32 (4.40–19.74) 43.12 < 0.001
Pain recorded 110 (73.1) 54 (38.0) 4.48 (2.73–7.36) 36.93 < 0.001
Sweating recorded 76 (50.7) 1 (0.7) 144.81 (19.74–1062.35) 93.78 < 0.001
Wound oozing recorded 72 (48.0) 28 (19.7) 3.76 (2.23–6.34) 25.91 < 0.001
Pedal pulses recorded 75 (50.0) 25 (17.6) 4.68 (2.73–8.01) 33.99 < 0.001
Glucose recorded 44 (29.3) 101 (71.1) 0.17 (0.10–0.28) 50.97 < 0.001
Hb recorded 67 (44.7) 89 (62.7) 0.48 (0.30–0.77) 9.51 0.002
Looks unwell recorded 100 (66.7) 4 (2.8) 69 (24.13–197.27) 129.69 < 0.001
No information found taken as sign/symptom not recorded, rather than the patient was not experiencing this sign/symptom. P values are reported to two
decimal places, except where the third place gives additional information as advised: P values >0.01 should be reported to two decimal places, those between
0.01 and 0.001 to three decimal places; P values smaller than 0.001 should be reported as P < 0.001 (The New England Journal of Medicine, https://www.nejm.org/
author-center/new-manuscripts, accessed 30.10.2019) [27]
RR respiratory rate, sats saturation percentage, HR heart rate, SBP systolic blood pressure, Hb haemoglobin
aUrine passed in the toilet was counted as recorded
bClinical parameters were not listed on the standard observation chart (control arm) but data were found in the patients’ progress notes and/or other documents
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reported incidence of tachycardia at MEWS level 2 elic-
ited a response.
Systolic blood pressure
In the intervention trial arm, 57 patients required review
for abnormal systolic blood pressure (Table 4). The
lower response rate in the intervention arm (1/57, 1.8%
vs 11/59, 18.6%) was statistically significant (P = 0.003,
OR 0.08 (0.01–0.63)). No low systolic blood pressure
(SBP) (≤ 90mmHg) recordings in the red range triggered
a response, and neither did the single recording for high
SBP (≥ 220mmHg). The single response was for MEWS
level 2 (92 mmHg) and the SBAR tool was used
appropriately.
In the control arm 23 of 142 (16.2%) patients had a
red MEWS value recorded for low SBP (≤ 90mmHg),
and 4 of 23 (17.4%) were actioned comprising 4/11
(36.4%) of the total responses. There were 4 of 11
(36.4%) responses for recordings of high SBP (≥ 220
mmHg) and 3 of 11 (27.3%) responses from 32 record-
ings for MEWS level 2 (91–100 mmHg).
Level of consciousness
There were few reported incidents: in the intervention
arm both reported incidents of a disturbed level of con-
sciousness were actioned, as were two of three reports
(66.7%) in the control arm.
Temperature
At a critical MEWS level of 3, there were 65/150 pa-
tients (43.6%) in the intervention arm with abnormally
low temperature recordings (≤ 35 °C) as their only ab-
normal sign; none of these elicited a response. Response
rate was similarly low in the control arm. Ward digital
thermometers were not calibrated regularly and the pro-
cedure for taking axillary temperatures was questionable:
nurses were observed placing the digital thermometer
between layers of clothing.
We regarded recordings of temperature readings as
unreliable and omitted these from Table 4. Had these re-
cordings been accurate, recordings would have triggered
calls for assistance for 45 of 150 (30.0%) patients in the
intervention arm and for 81 of 142 (57.0%) patients in
the control arm.
Urine output
For many patients in both trial arms, no urine output
was recorded (intervention arm: n = 107, 71.3%; control
arm: n = 69, 48.6%) and no responses were recorded. In
both trial arms a fluid balance (intake/output) chart for
recording urine output was used, and this was com-
pleted in preference to the MEWS chart in the interven-
tion arm. Most were recorded as passed urine in toilet
(PUIT). Volume was seldom measured on MEWS or
fluid balance charts (5/142, 3.5% in the control arm and
13/150, 8.7% in the intervention arm).
Serious adverse events (SAEs)
Few SAEs were recorded and there were no statistically
significant differences between trial arms (Table 5).
Discussion
It is reported that delayed recognition of deterioration of
patients on general wards can be attributed to human-
related monitoring failures [28]. Early detection of at-
risk patients requires regular and systematic assessment
Table 3 Patients with level-3 (red) MEWS vital signs recordings and responses in two trial arms
Number of level-3 MEWS vital signs recordings* Intervention arm
(n = 150)
Number (%)
Control arm
(n = 142)
Number (%)
OR (95% CI) P value
0 105 (70.0) 61 (43.0)
1 32 (21.3) 62 (43.7)
2 12 (8.0) 16 (11.3)
3 1 (0.7) 1 (0.7)
4 0 2 (1.4)
Patients with any red MEWS 45 (30.0) 81 (57.0) 0.32 (0.20–0.52) < 0.001
Assistance summoned
Yes 2 (4.4) 11 (13.6)
No but should have 43 (95.6) 70 (86.4) 0.29 (0.06–1.39) 0.03, 0.02 with
Yates’ correction
MEWS modified early warning score
P value reporting, see “Table 2” notes
aWe excluded:
• Temperature recordings, due to inconsistent measurement techniques and falsely low readings
• Urine output due to low numbers of recordings and almost zero recording of volume in both arms
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[29]. The primary outcome, nurses’ responses to early
signs of clinical and physiological deterioration, was dis-
appointing in both arms and the SBAR communication
guide for reporting clinical deterioration in intervention
wards was rarely used. Importantly, and for the first
time, this trial offers limited support for the assumed su-
periority of EWS/MEWS. This “no benefit” conclusion
can only be extended to the same or similar settings and
Table 4 Number of patients with recordings of abnormal vital signs that did/did not trigger responses at MEWS of 3 or 2 in two
trial arms
MEWS Vital signs Intervention arm
(n = 150)
Number (% of total)
Control arm
(n = 142)
Number (% of total)
OR (95% CI) P value (from
Fisher’s
exact test)
Respiratory rate (RR) (bpm)
3 25–50 9 (6.0) 61 (42.9)
2 21–24 34 (22.7) 9 (6.3)
Total abnormal RR 43 (28.7) 70 (49.3)
Rescued/assistance summoned Number (% of abnormal) Number (% of abnormal)
Yes, and should have 1 (2.3) 1 (1.4) 1.64 (0.10–26.97) 0.73
No, but should have 42 (97.7) 69 (98.6)
Oxygen saturation (%)
3 78–91 12 (8.0) 6 (4.2)
2 92–93 7 (4.7) 3 (2.1)
Total abnormal sats 19 (12.7) 9 (6.3)
Rescued/assistance summoned Number (% of abnormal) Number (% of abnormal)
Yes, and should have 0 5 (55.6) Cannot be computed 0.003
No, but should have 19 (100.0) 4 (44.4)
Heart rate (HR)
Upper 3 ≥ 131 8 (5.3) 7 (4.9)
Lower 3 ≤ 40 1 (0.7) 1 (0.7)
Upper 2 111–130 35 (23.3) 29 (20.4)
Total abnormal HR 44 (29.3) 37 (26.1)
Rescued / assistance summoned Number (% of abnormal) Number (% of abnormal)
Yes, and should have 2 (4.8) 1 (2.7) 1.71 (0.15–19.70) 0.66
No, but should have 42 (95.2) 36 (97.3)
Systolic Blood Pressure (SBP)
Upper 3 ≥ 220mmHg 1 (0.7) 4 (2.8)
Lower 3 ≤ 90 mmHg 28 (18.7) 23 (16.2)
Lower 2 91–100mmHg 28 (18.7) 32 (22.5)
Total Abnormal SBP 57 (38.0) 59 (41.5)
Rescued/assistance summoned Number (% of abnormal) Number (% of abnormal)
Yes, and should have 1 (1.8) 11 (18.6) 0.08 (0.01–0.63) 0.003
No, but should have 56 (98.2) 48 (81.4)
Level of consciousness (LOC)
3 Reacting to voice/pain/unresponsive 2 (1.3) 3 (2.1)
Total abnormal LOC 2 (1.3) 3 (2.1)
Rescued/assistance summoned Number (% of abnormal) Number (% of abnormal)
Yes, and should have 2 (100.0) 2 (66.7) Cannot be computed 0.36
No, but should have 0 1 (33.3)
Total abnormal recordings 165 178
P value reporting, see “Table 2” notes
MEWS modified early warning score, bpm breaths/minute, sats saturation percentages
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conditions pertaining to this trial: evaluation of paper-
based EWS instruments not previously used routinely,
gatekeepers declining access to researchers for ethically
approved studies, and the requirement for patient con-
sent for testing new nursing documentation posing low/
no risk to patient care. No similar studies were
identified.
Nurses in the control arm were more likely to respond
to abnormal physiology, except for level of conscious-
ness. Other than (likely spurious) low temperature re-
cordings, no assistance was summoned for a single red
MEWS for critical illness for 96% of affected patients in
the intervention arm and 86% of patients in the control
arm. Nurses largely relied on SBP, oxygen saturation and
level of consciousness when deciding on whether to
summon assistance, and tended to disregard respiration
rate. Nurses’ measurement of respiratory rate was found
to be unreliable [30].
Although axillary temperature is not considered accur-
ate [31] and is about 1 °F lower than oral temperature
[32], it was the conventional method of measurement on
public sector hospital wards in Cape Town at the time.
It is unusual for nurses to report low temperature
recordings.
There was a statistically significant difference between
the trial arms for recording of physiological parameters
listed on the MEWS observations chart but not on the
standard ward observations chart: oxygen saturation
(OR 5.49 (3.21–9.41), P < 0.001) and level of conscious-
ness (OR 2.83 (1.47–5.47), P = 0.001) (Table 2).
As reported elsewhere [1] clinical signs such as skin
tone, sweating, nausea or nurses’ intuitive assessment of
the patient being “just not right” and “looking unwell”
[33] should be monitored regularly to limit avoidable,
serious adverse events (SAEs) such as cardiac arrest, ur-
gent and unanticipated admission to an intensive care
unit (ICU) or even death. There was a statistically sig-
nificant difference between the trial arms for clinical pa-
rameters listed on the MEWS observations chart but not
on the standard ward observations chart: skin colour
(OR 9.32 (4.40–19.74), P < 0.001), pain (OR 4.48 (2.73–
7.36), P < 0.001), sweating (OR 144.81 (19.74–1062.35),
P < 0.001), wound oozing (OR 3.76 (2.23–6.34), P <
0.001), pedal pulses (OR 4.68 (2.73–8.01), P < 0.001),
and looks unwell (OR 69.0 (24.13–197.27), P < 0.001).
The MEWS ensured that such measurements were more
comprehensive, with two exceptions for glucose (OR
0.17 (0.10–0.28), P < 0.001), and haemoglobin (OR 0.48
(0.30–0.77), P <0.002) levels. There were too few SAEs
to draw any conclusions and the higher numbers of
SAEs in the intervention arm, despite fewer abnormal
vital signs, may have been due to complexities and intra-
hospital factors other than the type of observation chart.
Limitations, challenges and strengths
Our pilot study was not delivered as intended. However,
this trial has raised important questions about ethical
and regulatory challenges related to PCTs [16], including
the role of gatekeepers [17], and determination of what
constitutes “no more than minimal risk” research [18].
Gatekeeping recruitment and delivery
This was a two-hospital comparison, where, for ad-
ministrative and practical considerations, and to avoid
contamination [34], trial arm was dictated by hospital.
Whilst we acknowledge the limitation of this design
[35], this was the only available option after three
hospitals declined involvement. With only one hos-
pital in each arm, we were unable to adjust for hos-
pital characteristics, overt and tacit, and we
acknowledge this limitation. Preliminary data had in-
dicated that patients were similar in the two partici-
pating hospitals, and there were no marked
dissimilarities between the recruited samples. How-
ever, on data collection, consenting patients in the
intervention hospital were slightly older and more
likely to have been medicated. Similarly, recordings of
vital signs (unavailable before the study) indicated
that the patients in the control arm were probably
sicker (Tables 1, 2).
Gatekeepers critically shaped our trial [17]. During re-
cruitment, we were denied access to a hospital after an
8-month delay, justified by the commencement of a pilot
study on an electronic document system that included
the standard vital signs observations chart. The duration
of the training programme was reduced by hospital
Table 5 Serious adverse events recorded
SAE Intervention arm n = 150
Number (%)
Control arm n = 142 Number (%) OR (95%CI) P value
Any SAE 5 (3.3) 3 (2.1) 1.61 (0.38–6.86) 0.72 (Fisher’s)
Death *4 (2.7) 1 (0.7) 3.89 (0.43–35.23) 0.37 (Fisher’s)
Prolonged hospitalization 0 2 (1.4) Cannot be computed
ICU admission 1 (0.7) 0 Cannot be computed
*A specialist physician (UK) advised that a young patient diagnosed with chicken pox pneumonia and transferred from the intensive care unit to a medical
intervention ward, and whose vital signs were monitored by the standard chart, had died 2 h later. The physician expressed his opinion that had the MEWS been
used, the patient’s vital signs would probably have been better monitored, leading to interventions that might have saved his life
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managers, from a planned 8 h to 2 h, and this fell to 30–
60min on night duty, due to staff shortages. We do not
know the number of relief, agency or part-time nurses
who completed the MEWS charts without any training
from full-time staff. Failure to train agency nurses may
have affected study findings: nurse managers did not
give these nurses the opportunity to receive the training
on the intervention, because they were not considered to
be the hospital’s stable workforce. The clinical impact of
professional training courses varies [36]: whilst some au-
thors report the success of 1-day multi-media multi-
professional training courses [37, 38], others report no
significant changes [39]. Our teaching was limited to
nurses in full-time employment and the strategy in-
cluded a didactic approach, followed by clinical scenarios
to guide filling in blank MEWS charts, but might have
been enhanced by simulation [13]. No simulation labora-
tory was available in the hospital, and, at the time, there
were no facilities for online teaching and learning [13].
“No more than minimal risk” research
The study was less representative and smaller than
planned. Patient records could not be randomly selected
as the individual patient consenting process effectively
excluded ill patients and proved to be a barrier to
recruiting sufficient patients to achieve the required
sample size. We had aimed to recruit 51 patients in each
of 12 wards across 6 hospitals. We were able to recruit
292 eligible patients across 6 wards in 2 hospitals. We
recognise that this lower effective sample size detracts
from our trial and subsequent decision-making. Al-
though the previous Research Ethics Committee (REC)
in 2009 and funders (National Research Foundation,
South Africa) had agreed that consent would be ob-
tained at cluster (ward) level, restrictions were imposed
by the REC in 2014 on the consenting process for collec-
tion of anonymised data from hospital records [40].
As this was a trial of nursing documentation, without
patient contact, and patients are not normally consulted
about the design of nursing charts for recording vital
signs, or other nursing documentation, we had antici-
pated compliance with the Ottawa Statement, integral to
the CONSORT statement [41–43] and recommenda-
tions for PCTs [16, 18]. The limited available resources
to consent patients are reflected in the reduced number
of participants, indicating that findings must be inter-
preted with caution and regarded as preliminary. Largely
due to the exclusion of the patients who were the most
ill, there were small numbers in outcome variables (two
subjects in the key outcome in the intervention arm),
precluding adjusted analyses [26]. We made no adjust-
ment for multiple testing. A larger sample would have
been unlikely to reverse our findings; however, we can
only speculate as to whether the original multi-site study
with an unbiased patient sample would have yielded
similar findings.
HIV status was not a consideration for this study.
Zambia, a developing country, with a significant HIV
burden, demonstrated no significant difference in
early warning scores when comparing patients with
different HIV status (HIV positive, negative or un-
known), P = 0.51 [44].
Generalisation
From single-centre research, we cannot assume that
findings can necessarily be generalised to settings where
the prevalence of the conditions under consideration or
nurse-to-patient ratio or nurses’ educational levels or
communication ethos may differ [45, 46]. Furthermore,
resources did not extend to qualitative analyses of
nurses’ perceptions of the MEWS charts [47]. However,
the staffing and case mix are representative of hospitals
in Cape Town. The non-participation of three hospitals
and patients unwilling or too ill to consent to the review
of records by researchers introduces a potential for vol-
unteer bias. We cannot generalise our findings to sicker
patients or settings less willing to participate in research
[48], and clinical trial volunteers are often of higher so-
cioeconomic status than those who decline [49]. Had all
patients been included, the prevalence of the “summon-
ing assistance” outcome variables might have been suffi-
cient for a more robust analysis.
Sources of bias
Blinding: it is rarely possible to blind staff participants in
trials of documentation, but patients were unlikely to
have been aware of their allocation. As the MEWS
charts were in patients’ records in the intervention
wards, it was not possible to blind the independent rec-
ord reviewers to trial arm. Blinding of staff during ad-
ministration of the intervention, data capture and
outcome assessment in non-pharmacological [40], clus-
ter [50] or pragmatic trials may be impossible [24], in-
creasing the risk of bias [22] in line with observers’
expectations [51]. Bias in the detection of outcomes was
minimised, but not removed, by a pre-arranged data col-
lection template and the low subjectivity of outcome
data extracted from standardised documentation, such
as vital signs’ records [35]. There were no obvious differ-
ences between the two arms in outcomes; therefore data
analysts could not guess whether A or B was the inter-
vention arm. Findings favouring the control arm offer
no evidence that the study team were influenced by the
Rosenthal effect [51] and entrapment by prior expect-
ation [52]. Systematic review indicates that some 3% un-
blinded assessments are likely to be misclassified [53],
which would not materially affect interpretation of our
study.
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Our findings are dependent on the reliability and com-
pleteness of patient records. There were several in-
stances where summoning senior assistance would have
been warranted, but this was not documented: we could
only conclude that this was not done [54]. We have no
reason to suppose that this and the Hawthorne effect
[55] would have affected the arms unequally.
Conclusions
Despite shortcomings, our pilot trial can contribute to a
“learning healthcare system” [56] in which continuous
learning takes place in the context of routine patient
care towards providing answers to clinical questions
[16]. The revised CT MEWS observations chart im-
proved recording of certain physiological and all clinical
parameters when compared to the standard chart but
did not improve nurses’ ability to identify early signs of
clinical deterioration and summon assistance. Recruit-
ment of only two hospitals limits generalisation of these
findings. Further work is needed on educational prepar-
ation for the CT MEWS/SBAR and testing impact on
nurses’ reporting behaviour.
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